Search Within

Mabel M Ryder

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  2. Department of Medicine (15)
  3. Division of Subspecialty Medicine (15)
  4. Endocrinology (15)
  5. GSK Faculty (15)
  6. Human Oncology and Pathogenesis Program (15)

More Groups

People
  1. James Fagin (15)
  2. Ronald Ghossein (13)
  3. Jeffrey Knauf (10)
  4. Marc Ladanyi (4)
  5. Cristina Montero-Conde (3)
  6. Dhananjay Chitale (3)

More People

Years
  1. 2023 (1)
  2. 2017 (1)
  3. 2014 (1)
  4. 2013 (4)
  5. 2012 (1)
  6. 2011 (2)

More Years

Publications
  1. Endocrine-Related Cancer (3)
  2. Cancer Research (2)
  3. Cancer Discovery (1)
  4. Clinical Cancer Research (1)
  5. International Journal of Cancer (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Bioscientifica Ltd (3)
  3. Nature Publishing Group (2)
  4. American Society for Clinical Investigation (1)
  5. John Wiley & Sons (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy
    Journal Article

    Boucai, L.; Saqcena, M.; Kuo, F.; Grewal, R. K.; Socci, N.; Knauf, J. A.; Krishnamoorthy, G. P.; Ryder, M.; Ho, A. L.; Ghossein, R. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene
    Journal Article

    Montero-Conde, C.; Leandro-Garcia, L. J.; Chen, X.; Oler, G.; Ruiz-Llorente, S.; Ryder, M.; Landa, I.; Sanchez-Vega, F.; La, K.; Ghossein, R. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2017)

    Fulltext@MSK | Save
  • Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: A comprehensive retrospective review from a single institution
    Journal Article

    Ryder, M.; Callahan, M.; Postow, M. A.; Wolchok, J.; Fagin, J. A.
    Endocrine-Related Cancer (2014)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF mutant thyroid carcinomas
    Meeting Abstract

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
    Journal Article

    Gild, M. L.; Landa, I.; Ryder, M.; Ghossein, R. A.; Knauf, J. A.; Fagin, J. A.
    Endocrine-Related Cancer (2013)

    Fulltext@MSK | Save
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
    Journal Article

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
    Journal Article

    Ryder, M.; Gild, M.; Hohl, T. M.; Pamer, E.; Knauf, J.; Ghossein, R.; Joyce, J. A.; Fagin, J. A.
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Absence of common activating mutations of the epidermal growth factor receptor gene in thyroid cancers from American and Japanese patients
    Journal Article

    Ricarte-Filho, J. C.; Matsuse, M.; Lau, C.; Ryder, M.; Nishihara, E.; Ghossein, R. A.; Ladanyi, M.; Yamashita, S.; Mitsutake, N.; Fagin, J. A.
    International Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Journal Article

    Chakravarty, D.; Santos, E.; Ryder, M.; Knauf, J. A.; Liao, X. H.; West, B. L.; Bollag, G.; Kolesnick, R.; Thin, T. H.; Rosen, N.; more...
    Journal of Clinical Investigation (2011)

    Fulltext@MSK | Save
  • Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFΒ signaling
    Journal Article

    Knauf, J. A.; Sartor, M. A.; Medvedovic, M.; Lundsmith, E.; Ryder, M.; Salzano, M.; Nikiforov, Y. E.; Giordano, T. J.; Ghossein, R. A.; Fagin, J. A.
    Oncogene (2011)

    Fulltext@MSK | Save